167 related articles for article (PubMed ID: 19304784)
1. Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study.
Song H; Ramus SJ; Kjaer SK; DiCioccio RA; Chenevix-Trench G; Pearce CL; Hogdall E; Whittemore AS; McGuire V; Hogdall C; Blaakaer J; Wu AH; Van Den Berg DJ; Stram DO; Menon U; Gentry-Maharaj A; Jacobs IJ; Webb PM; Beesley J; Chen X; ; ; Rossing MA; Doherty JA; Chang-Claude J; Wang-Gohrke S; Goodman MT; Lurie G; Thompson PJ; Carney ME; Ness RB; Moysich K; Goode EL; Vierkant RA; Cunningham JM; Anderson S; Schildkraut JM; Berchuck A; Iversen ES; Moorman PG; Garcia-Closas M; Chanock S; Lissowska J; Brinton L; Anton-Culver H; Ziogas A; Brewster WR; Ponder BA; Easton DF; Gayther SA; Pharoah PD;
Hum Mol Genet; 2009 Jun; 18(12):2297-304. PubMed ID: 19304784
[TBL] [Abstract][Full Text] [Related]
2. Association study of prostate cancer susceptibility variants with risks of invasive ovarian, breast, and colorectal cancer.
Song H; Koessler T; Ahmed S; Ramus SJ; Kjaer SK; Dicioccio RA; Wozniak E; Hogdall E; Whittemore AS; McGuire V; Ponder BA; Turnbull C; Hines S; Rahman N; ; Eeles RA; Easton DF; Gayther SA; Dunning AM; Pharoah PD
Cancer Res; 2008 Nov; 68(21):8837-42. PubMed ID: 18974127
[TBL] [Abstract][Full Text] [Related]
3. Tagging single nucleotide polymorphisms in the BRIP1 gene and susceptibility to breast and ovarian cancer.
Song H; Ramus SJ; Kjaer SK; Hogdall E; Dicioccio RA; Whittemore AS; McGuire V; Hogdall C; Jacobs IJ; Easton DF; Ponder BA; Dunning AM; Gayther SA; Pharoah PD
PLoS One; 2007 Mar; 2(3):e268. PubMed ID: 17342202
[TBL] [Abstract][Full Text] [Related]
4. Association between common germline genetic variation in 94 candidate genes or regions and risks of invasive epithelial ovarian cancer.
Quaye L; Tyrer J; Ramus SJ; Song H; Wozniak E; DiCioccio RA; McGuire V; Høgdall E; Høgdall C; Blaakaer J; Goode EL; Schildkraut JM; Easton DF; Krüger-Kjaer S; Whittemore AS; Gayther SA; Pharoah PD
PLoS One; 2009 Jun; 4(6):e5983. PubMed ID: 19543528
[TBL] [Abstract][Full Text] [Related]
5. A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2.
Song H; Ramus SJ; Tyrer J; Bolton KL; Gentry-Maharaj A; Wozniak E; Anton-Culver H; Chang-Claude J; Cramer DW; DiCioccio R; Dörk T; Goode EL; Goodman MT; Schildkraut JM; Sellers T; Baglietto L; Beckmann MW; Beesley J; Blaakaer J; Carney ME; Chanock S; Chen Z; Cunningham JM; Dicks E; Doherty JA; Dürst M; Ekici AB; Fenstermacher D; Fridley BL; Giles G; Gore ME; De Vivo I; Hillemanns P; Hogdall C; Hogdall E; Iversen ES; Jacobs IJ; Jakubowska A; Li D; Lissowska J; Lubiński J; Lurie G; McGuire V; McLaughlin J; Medrek K; Moorman PG; Moysich K; Narod S; Phelan C; Pye C; Risch H; Runnebaum IB; Severi G; Southey M; Stram DO; Thiel FC; Terry KL; Tsai YY; Tworoger SS; Van Den Berg DJ; Vierkant RA; Wang-Gohrke S; Webb PM; Wilkens LR; Wu AH; Yang H; Brewster W; Ziogas A; ; ; ; Houlston R; Tomlinson I; Whittemore AS; Rossing MA; Ponder BA; Pearce CL; Ness RB; Menon U; Kjaer SK; Gronwald J; Garcia-Closas M; Fasching PA; Easton DF; Chenevix-Trench G; Berchuck A; Pharoah PD; Gayther SA
Nat Genet; 2009 Sep; 41(9):996-1000. PubMed ID: 19648919
[TBL] [Abstract][Full Text] [Related]
6. Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium.
Campa D; Kaaks R; Le Marchand L; Haiman CA; Travis RC; Berg CD; Buring JE; Chanock SJ; Diver WR; Dostal L; Fournier A; Hankinson SE; Henderson BE; Hoover RN; Isaacs C; Johansson M; Kolonel LN; Kraft P; Lee IM; McCarty CA; Overvad K; Panico S; Peeters PH; Riboli E; Sanchez MJ; Schumacher FR; Skeie G; Stram DO; Thun MJ; Trichopoulos D; Zhang S; Ziegler RG; Hunter DJ; Lindström S; Canzian F
J Natl Cancer Inst; 2011 Aug; 103(16):1252-63. PubMed ID: 21791674
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot".
Johnatty SE; Beesley J; Chen X; Macgregor S; Duffy DL; Spurdle AB; deFazio A; Gava N; Webb PM; Rossing MA; Doherty JA; Goodman MT; Lurie G; Thompson PJ; Wilkens LR; Ness RB; Moysich KB; Chang-Claude J; Wang-Gohrke S; Cramer DW; Terry KL; Hankinson SE; Tworoger SS; Garcia-Closas M; Yang H; Lissowska J; Chanock SJ; Pharoah PD; Song H; Whitemore AS; Pearce CL; Stram DO; Wu AH; Pike MC; Gayther SA; Ramus SJ; Menon U; Gentry-Maharaj A; Anton-Culver H; Ziogas A; Hogdall E; Kjaer SK; Hogdall C; Berchuck A; Schildkraut JM; Iversen ES; Moorman PG; Phelan CM; Sellers TA; Cunningham JM; Vierkant RA; Rider DN; Goode EL; Haviv I; Chenevix-Trench G; ; ;
PLoS Genet; 2010 Jul; 6(7):e1001016. PubMed ID: 20628624
[TBL] [Abstract][Full Text] [Related]
8. Common genetic variants associated with breast cancer in Korean women and differential susceptibility according to intrinsic subtype.
Han W; Woo JH; Yu JH; Lee MJ; Moon HG; Kang D; Noh DY
Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):793-8. PubMed ID: 21415360
[TBL] [Abstract][Full Text] [Related]
9. Inherited common variants in mitochondrial DNA and invasive serous epithelial ovarian cancer risk.
Earp MA; Brooks-Wilson A; Cook L; Le N
BMC Res Notes; 2013 Oct; 6():425. PubMed ID: 24148579
[TBL] [Abstract][Full Text] [Related]
10. Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer, and Radiation Epidemiology (WECARE) Study.
Teraoka SN; Bernstein JL; Reiner AS; Haile RW; Bernstein L; Lynch CF; Malone KE; Stovall M; Capanu M; Liang X; Smith SA; Mychaleckyj J; Hou X; Mellemkjaer L; Boice JD; Siniard A; Duggan D; Thomas DC; ; Concannon P
Breast Cancer Res; 2011; 13(6):R114. PubMed ID: 22087758
[TBL] [Abstract][Full Text] [Related]
11. Replication study for the association of seven genome- GWAS-identified Loci with susceptibility to ovarian cancer in the Polish population.
Mostowska A; Sajdak S; Pawlik P; Markowska J; Pawałowska M; Lianeri M; Jagodzinski PP
Pathol Oncol Res; 2015 Apr; 21(2):307-13. PubMed ID: 25173882
[TBL] [Abstract][Full Text] [Related]
12. Replication of five GWAS-identified loci and breast cancer risk among Hispanic and non-Hispanic white women living in the Southwestern United States.
Slattery ML; Baumgartner KB; Giuliano AR; Byers T; Herrick JS; Wolff RK
Breast Cancer Res Treat; 2011 Sep; 129(2):531-9. PubMed ID: 21475998
[TBL] [Abstract][Full Text] [Related]
13. ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study.
Doherty JA; Rossing MA; Cushing-Haugen KL; Chen C; Van Den Berg DJ; Wu AH; Pike MC; Ness RB; Moysich K; Chenevix-Trench G; Beesley J; Webb PM; Chang-Claude J; Wang-Gohrke S; Goodman MT; Lurie G; Thompson PJ; Carney ME; Hogdall E; Kjaer SK; Hogdall C; Goode EL; Cunningham JM; Fridley BL; Vierkant RA; Berchuck A; Moorman PG; Schildkraut JM; Palmieri RT; Cramer DW; Terry KL; Yang HP; Garcia-Closas M; Chanock S; Lissowska J; Song H; Pharoah PD; Shah M; Perkins B; McGuire V; Whittemore AS; Di Cioccio RA; Gentry-Maharaj A; Menon U; Gayther SA; Ramus SJ; Ziogas A; Brewster W; Anton-Culver H; ; ; Pearce CL;
Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):245-50. PubMed ID: 20056644
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study.
Lee AW; Tyrer JP; Doherty JA; Stram DA; Kupryjanczyk J; Dansonka-Mieszkowska A; Plisiecka-Halasa J; Spiewankiewicz B; Myers EJ; ; ; Chenevix-Trench G; Fasching PA; Beckmann MW; Ekici AB; Hein A; Vergote I; Van Nieuwenhuysen E; Lambrechts D; Wicklund KG; Eilber U; Wang-Gohrke S; Chang-Claude J; Rudolph A; Sucheston-Campbell L; Odunsi K; Moysich KB; Shvetsov YB; Thompson PJ; Goodman MT; Wilkens LR; Dörk T; Hillemanns P; Dürst M; Runnebaum IB; Bogdanova N; Pelttari LM; Nevanlinna H; Leminen A; Edwards RP; Kelley JL; Harter P; Schwaab I; Heitz F; du Bois A; Orsulic S; Lester J; Walsh C; Karlan BY; Hogdall E; Kjaer SK; Jensen A; Vierkant RA; Cunningham JM; Goode EL; Fridley BL; Southey MC; Giles GG; Bruinsma F; Wu X; Hildebrandt MA; Lu K; Liang D; Bisogna M; Levine DA; Weber RP; Schildkraut JM; Iversen ES; Berchuck A; Terry KL; Cramer DW; Tworoger SS; Poole EM; Olson SH; Orlow I; Bandera EV; Bjorge L; Tangen IL; Salvesen HB; Krakstad C; Massuger LF; Kiemeney LA; Aben KK; van Altena AM; Bean Y; Pejovic T; Kellar M; Le ND; Cook LS; Kelemen LE; Brooks-Wilson A; Lubinski J; Gronwald J; Cybulski C; Jakubowska A; Wentzensen N; Brinton LA; Lissowska J; Yang H; Nedergaard L; Lundvall L; Hogdall C; Song H; Campbell IG; Eccles D; Glasspool R; Siddiqui N; Carty K; Paul J; McNeish IA; Sieh W; McGuire V; Rothstein JH; Whittemore AS; McLaughlin JR; Risch HA; Phelan CM; Anton-Culver H; Ziogas A; Menon U; Ramus SJ; Gentry-Maharaj A; Harrington P; Pike MC; Modugno F; Rossing MA; Ness RB; Pharoah PD; Stram DO; Wu AH; Pearce CL
Gynecol Oncol; 2015 Mar; 136(3):542-8. PubMed ID: 25528498
[TBL] [Abstract][Full Text] [Related]
15. Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer.
Lawrenson K; Iversen ES; Tyrer J; Weber RP; Concannon P; Hazelett DJ; Li Q; Marks JR; Berchuck A; Lee JM; Aben KK; Anton-Culver H; Antonenkova N; ; ; Bandera EV; Bean Y; Beckmann MW; Bisogna M; Bjorge L; Bogdanova N; Brinton LA; Brooks-Wilson A; Bruinsma F; Butzow R; Campbell IG; Carty K; Chang-Claude J; Chenevix-Trench G; Chen A; Chen Z; Cook LS; Cramer DW; Cunningham JM; Cybulski C; Plisiecka-Halasa J; Dennis J; Dicks E; Doherty JA; Dörk T; du Bois A; Eccles D; Easton DT; Edwards RP; Eilber U; Ekici AB; Fasching PA; Fridley BL; Gao YT; Gentry-Maharaj A; Giles GG; Glasspool R; Goode EL; Goodman MT; Gronwald J; Harter P; Hasmad HN; Hein A; Heitz F; Hildebrandt MA; Hillemanns P; Hogdall E; Hogdall C; Hosono S; Jakubowska A; Paul J; Jensen A; Karlan BY; Kjaer SK; Kelemen LE; Kellar M; Kelley JL; Kiemeney LA; Krakstad C; Lambrechts D; Lambrechts S; Le ND; Lee AW; Cannioto R; Leminen A; Lester J; Levine DA; Liang D; Lissowska J; Lu K; Lubinski J; Lundvall L; Massuger LF; Matsuo K; McGuire V; McLaughlin JR; Nevanlinna H; McNeish I; Menon U; Modugno F; Moysich KB; Narod SA; Nedergaard L; Ness RB; Noor Azmi MA; Odunsi K; Olson SH; Orlow I; Orsulic S; Pearce CL; Pejovic T; Pelttari LM; Permuth-Wey J; Phelan CM; Pike MC; Poole EM; Ramus SJ; Risch HA; Rosen B; Rossing MA; Rothstein JH; Rudolph A; Runnebaum IB; Rzepecka IK; Salvesen HB; Budzilowska A; Sellers TA; Shu XO; Shvetsov YB; Siddiqui N; Sieh W; Song H; Southey MC; Sucheston L; Tangen IL; Teo SH; Terry KL; Thompson PJ; Timorek A; Tworoger SS; Van Nieuwenhuysen E; Vergote I; Vierkant RA; Wang-Gohrke S; Walsh C; Wentzensen N; Whittemore AS; Wicklund KG; Wilkens LR; Woo YL; Wu X; Wu AH; Yang H; Zheng W; Ziogas A; Coetzee GA; Freedman ML; Monteiro AN; Moes-Sosnowska J; Kupryjanczyk J; Pharoah PD; Gayther SA; Schildkraut JM
Carcinogenesis; 2015 Nov; 36(11):1341-53. PubMed ID: 26424751
[TBL] [Abstract][Full Text] [Related]
16. Genetic ancestry modifies the association between genetic risk variants and breast cancer risk among Hispanic and non-Hispanic white women.
Fejerman L; Stern MC; Ziv E; John EM; Torres-Mejia G; Hines LM; Wolff R; Wang W; Baumgartner KB; Giuliano AR; Slattery ML
Carcinogenesis; 2013 Aug; 34(8):1787-93. PubMed ID: 23563089
[TBL] [Abstract][Full Text] [Related]
17. [Polymorphisms of microRNA genes and their association with breast cancer risk].
Zhang P; Ma F; Xu B
Zhonghua Zhong Liu Za Zhi; 2015 Jul; 37(7):501-7. PubMed ID: 26463325
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer susceptibility polymorphism rs2660753 is not associated with invasive ovarian cancer.
Amankwah EK; Kelemen LE; Wang Q; Song H; Chenevix-Trench G; ; Beesley J; Webb PM; ; Pearce CL; Wu AH; Pike MC; Stram DO; Chang-Claude J; Wang-Gohrke S; Ness RB; Goode EL; Cunningham JM; Fridley BL; Vierkant RA; Tworoger SS; Whittemore AS; McGuire V; Sieh W; Gayther SA; Gentry-Maharaj A; Menon U; Ramus SJ; Rossing MA; Doherty JA; Goodman MT; Carney ME; Lurie G; Wilkens LR; Kjær SK; Høgdall E; Cramer DW; Terry KL; Garcia-Closas M; Yang H; Lissowska J; Anton-Culver H; Ziogas A; Schildkraut JM; Berchuck A; Pharoah PD;
Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):1028-31. PubMed ID: 21415361
[TBL] [Abstract][Full Text] [Related]
19. Consortium analysis of 7 candidate SNPs for ovarian cancer.
Ramus SJ; Vierkant RA; Johnatty SE; Pike MC; Van Den Berg DJ; Wu AH; Pearce CL; Menon U; Gentry-Maharaj A; Gayther SA; DiCioccio RA; McGuire V; Whittemore AS; Song H; Easton DF; Pharoah PDP; Garcia-Closas M; Chanock S; Lissowska J; Brinton L; Terry KL; Cramer DW; Tworoger SS; Hankinson SE; Berchuck A; Moorman PG; Schildkraut JM; Cunningham JM; Liebow M; Kjaer SK; Hogdall E; Hogdall C; Blaakaer J; Ness RB; Moysich KB; Edwards RP; Carney ME; Lurie G; Goodman MT; Wang-Gohrke S; Kropp S; Chang-Claude J; Webb PM; Chen X; Beesley J; Chenevix-Trench G; Goode EL
Int J Cancer; 2008 Jul; 123(2):380-388. PubMed ID: 18431743
[TBL] [Abstract][Full Text] [Related]
20. Variation at 8q24 and 9p24 and risk of epithelial ovarian cancer.
White KL; Sellers TA; Fridley BL; Vierkant RA; Phelan CM; Tsai YY; Kalli KR; Berchuck A; Iversen ES; Hartmann LC; Liebow M; Armasu S; Fredericksen Z; Larson MC; Duggan D; Couch FJ; Schildkraut JM; Cunningham JM; Goode EL
Twin Res Hum Genet; 2010 Feb; 13(1):43-56. PubMed ID: 20158306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
